Physician
Internal Medicine
Dr. Jennifer K. Litton, MD
|
|
Give Review
Doctor Jennifer K. Litton, MD is an expert in the field of Internal Medicine. She attended University of Massachusetts Medical School. University of Massachusetts Medical School has a rank of 49 in research and a 12 in primary care Jennifer Litton is a published doctor as well. She has 59 publications published. The latest was: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. She is registered with Medicare and accepts Medicare payments.
Publications
- Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
- Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.
- Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.
- Hereditary breast Cancer syndromes and genetic testing.
- Receptor Status Change From Primary to Residual Breast Cancer After Neoadjuvant Chemotherapy and Analysis of Survival Outcomes.
- Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
- Breast Cancer, BRCA Mutations, and Attitudes Regarding Pregnancy and Preimplantation Genetic Diagnosis.
- Predictors that Influence Contralateral Prophylactic Mastectomy Election Among Women with Ductal Carcinoma In Situ Who Were Evaluated for BRCA Genetic Testing.
- PD-L1 Expression in Triple-Negative Breast Cancer.
- Open label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC vs. the combination of paclitaxel and everolimus followed by ...
- Characteristics of individuals with breast Cancer rearrangements in BRCA1 and BRCA2.
- Reply to D. Crivellari et al.
- Effect of Age and Race On Quality of Life in Young Breast Cancer Survivors.
- Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary Cancer syndromes.
- Pregnancy during or after breast Cancer diagnosis: what do we know and what do we need to know?
- Fertility preservation in women with breast Cancer: challenges and opportunities.
- Breast Cancer in the young: role of the geneticist.
- Outcomes and Predictive Factors for Salvage Therapy After Local-Regional Recurrence Following Neoadjuvant Chemotherapy and Breast Conserving Therapy.
- Outcome of metastatic breast Cancer in selected women with or without deleterious BRCA mutations.
- USP-11 as a Predictive and Prognostic Factor Following Neoadjuvant Therapy in Women With Breast Cancer.
- Evaluating breast Cancer risk with genome-wide association studies: is this approach patient ready?
- Genotype in BRCA-associated Breast Cancers.
- Biologic features and prognosis of ductal Carcinoma in situ are not adversely impacted by initial large body mass.
- Breast Cancer and fertility.
- Aromatase inhibitors and breast Cancer prevention.
- Triple-negative breast Cancer is not a contraindication for breast conservation.
- Earlier age of onset of BRCA mutation-related Cancers in subsequent generations.
- Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience.
- Outcome of triple-negative breast Cancer in patients with or without deleterious BRCA mutations.
- Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast Cancer.
- Age and Survival Estimates in Patients Who Have Node-Negative T1ab Breast Cancer by Breast Cancer Subtype.
- Early onset HER2-positive breast Cancer is associated with germline TP53 mutations.
- Management of local-regional recurrence following immediate breast reconstruction in patients with early breast Cancer treated without postmastectomy radiotherapy.
- Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast Cancer.
- Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast Cancer.
- Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing T...
- Sentinel lymph node dissection is technically feasible in older breast Cancer patients.
- Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast Cancers.
- Breast Cancer and pregnancy: current concepts in diagnosis and treatment.
- High risk of recurrence for patients with breast Cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.
- Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
- The impact of pregnancy on breast Cancer outcomes in women<or=35 years.
- Ten-year recurrence rates in young women with breast Cancer by locoregional treatment approach.
- Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast Cancer.
- Multifocal breast Cancer in women < or =35 years old.
- Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast...
- Clinical application of breast Cancer risk assessment models.
- Wound complications from surgery in pregnancy-associated breast Cancer (PABC).
- Breast Cancer diagnosis during pregnancy.
- Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center.
- Pathologic complete response in breast Cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity.
- Clinicopathologic factors associated with involved margins after Breast-conserving surgery for invasive lobular carcinoma.
- Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast Cancer aged 35 years or younger.
- Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast Cancer.
- Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast Cancer.
- Expression and Relevance of TRPS-1: A New GATA Transcription Factor in Breast Cancer.
- Factors affecting the decision of breast Cancer patients to undergo contralateral prophylactic mastectomy.
- Breast Cancer before age 40 years.
Schools
Univ Of Ma Med Sch
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Anemia
- Bladder Cancer
- Breast Cancer
- Carcinoma in Situ
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
Education
-
University of Texas Health Science Center -
Baylor College of Medicine -
University of Massachusetts Medical School
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1821196759 | |
| NPPES Provider LastName | LITTON | |
| NPPES Provider FirstName | JENNIFER | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 293.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 4.44 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821196759 |
| Last Name Of The Provider | LITTON |
| First Name Of The Provider | JENNIFER |
| View All |
Similar Doctors
|
Dr. Maha B. Toma, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jimmie E. Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arber Kodra, MD |
|
|
Dr. Arun T. Jacob, MD |
|
|
Dr. Cara A. Foldes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry J. Conter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Young Kwang Chae, MD |
|
|
Dr. Marco G. De Lima, MD |
|
|
Dr. Antonio C. Buzaid, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Florencia M. McAllister, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Wagner, MD |
|
Dr. Roger W. Schultz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sidharth N. Ghosh, MD
This Doctor is OpenDoctor Recommended.
|